Results for &quot;&quot;Tachycardia, Paroxysmal&quot;&quot;[mesh_terms]

Rationale and design of the NODE-303 study: evaluating the safety of symptom-prompted, self-administered etripamil for paroxysmal supraventricular tachycardia episodes in real-world settings.

Bruce Stambler, Samuel F Sears, Narendra Singh, Peter A Noseworthy, David B Bharucha, Silvia Shardonofsky, James E Ip, Benoit Coutu, A John Camm, Hanh Bui, Maria Leonor Parody, Juan Agudelo Uribe, John Vyselaar, Sarah Omodele

American heart journal 2024;270():55-61

First Randomized, Multicenter, Placebo-Controlled Study of Self-Administered Intranasal Etripamil for Acute Conversion of Spontaneous Paroxysmal Supraventricular Tachycardia (NODE-301).

Bruce S Stambler, Francis Plat, Philip T Sager, Silvia Shardonofsky, Douglas Wight, Diane Potvin, A Shekhar Pandey, James E Ip, Benoit Coutu, Blandine Mondésert, Laurence D Sterns, Matthew Bennett, Jeffrey L Anderson, Roger Damle, Ronald Haberman, A John Camm

Circulation. Arrhythmia and electrophysiology 2022;15(12):e010915

Self-administered intranasal etripamil using a symptom-prompted, repeat-dose regimen for atrioventricular-nodal-dependent supraventricular tachycardia (RAPID): a multicentre, randomised trial.

Bruce S Stambler, A John Camm, Marco Alings, Paul Dorian, Hein Heidbuchel, Jaco Houtgraaf, Peter R Kowey, Jose L Merino, Blandine Mondésert, Jonathan P Piccini, Sean D Pokorney, Philip T Sager, Atul Verma, J Marcus Wharton, David B Bharucha, Francis Plat, Silvia Shardonofsky, Michael Chen, James E Ip

Lancet (London, England) 2023;402(10396):118-128

Intranasal etripamil for rapid treatment of paroxysmal supraventricular tachycardia.

Peter Calvert, Dhiraj Gupta

Future cardiology 2024;20(3):163-170

Etripamil nasal spray: an investigational agent for the rapid termination of paroxysmal supraventricular tachycardia (SVT).

Anthony H Kashou, Peter A Noseworthy

Expert opinion on investigational drugs 2020;29(1):1-4

Etripamil Nasal Spray for Conversion of Repeated Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia During Long-Term Follow-Up: Results From the NODE-302 Study.

James E Ip, Benoit Coutu, Matthew T Bennett, A Shekhar Pandey, Bruce S Stambler, Philip Sager, Michael Chen, Silvia Shardonofsky, Francis Plat, A John Camm

Journal of the American Heart Association 2023;12(19):e028227

Adenosine cardioprotection study in clinical setting of paroxysmal supraventricular tachycardia.

Ivana I Vranic, Mihailo Matic, Jovan Perunicic, Tijana Simic, Ljiljana Soskic, Natasa Milic

Prostaglandins, leukotrienes, and essential fatty acids 2006;74(6):365-71

Etripamil: Intranasal Calcium Channel Blocker: A Novel Noninvasive Modality in the Treatment of Paroxysmal Supraventricular Tachycardia.

Joel M Raja, Brandon Cave, John L Jefferies, Rami N Khouzam

Current problems in cardiology 2021;46(3):100430

Intravenous magnesium sulfate versus diltiazem in paroxysmal atrial fibrillation.

J A Chiladakis, C Stathopoulos, P Davlouros, A S Manolis

International journal of cardiology 2001;79(2-3):287-91

Efficacy and safety of dabigatran compared to warfarin in patients with paroxysmal, persistent, and permanent atrial fibrillation: results from the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) study.

Greg Flaker, Michael Ezekowitz, Salim Yusuf, Lars Wallentin, Herbert Noack, Martina Brueckmann, Paul Reilly, Stefan H Hohnloser, Stuart Connolly

Journal of the American College of Cardiology 2012;59(9):854-5

Pharmacologic management of atrial fibrillation: current therapeutic strategies.

S Lévy

American heart journal 2001;141(2 Suppl):S15-21

Anticoagulation in atrial fibrillation: a contemporary viewpoint.

D George Wyse

Heart rhythm 2007;4(3 Suppl):S34-9

Dose-related cardiac electrophysiological effects of intravenous magnesium. A double-blind placebo-controlled dose-response study in patients with paroxysmal supraventricular tachycardia.

F Andreasen, E H Christiansen, L Frost, P Mortensen, P E Thomsen, A K Pedersen

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2001;2(4):320-6